Spatial OMICS Market Growth, Size, Trends Analysis - By Technology, By Product, By Application, By Workflow, By End-User - Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Description

Spatial OMICS Market Introduction and Overview

According to SPER Market Research, 'Global Spatial OMICS Market Size- By Technology, By Product, By Application, By Workflow, By End-User - Regional Outlook, Competitive Strategies and Segment Forecast to 2034' state that the Global Spatial OMICS Market is predicted to reach 3253.89 million by 2034 with a CAGR of 16.52%.

Spatial OMICS pertains to the investigation of integrating various analyses including proteomics, lipidomics, genomics, epigenomics, transcriptomics, and metabolomics. Additionally, Spatial OMICS melds molecular analysis with specific information regarding cell localization within the tissue. This field enables researchers to pinpoint gene activity within tissue samples as well as to delineate the regions where such activity is occurring. Furthermore, it aids in comprehending the biological processes underpinning diseases.

Restraints: The spatial OMICS market experiences notable constraints stemming from the challenges associated with managing extensive and complex datasets produced by this technology. Spatial OMICS produces a substantial volume of multi-dimensional data, which encompasses spatial coordinates, gene expression levels, and cellular interactions. The analysis and management of these data demand considerable computational resources, specialized software, and proficient data scientists.

Scope of the report:

Report Metric Details

Market size available for years 2021-2034

Base year considered 2024

Forecast period 2025-2034

Segments covered By Technology, By Product, By Application, By Workflow, By End-User

Regions covered North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa

Companies Covered

10x Genomics, Akoya Biosciences, Inc, Bio-Techne Corporation, BioSpyder, Inc, Bruker Corporation, Danaher Corporation, Diagenode Diagnostics (Hologic, Inc), Ionpath, Inc, Millennium Science Pty Ltd, NanoString Technologies, Inc.

Global Spatial OMICS Market Segmentation:

By Technology: Based on the Technology, Global Spatial OMICS Market is segmented as; Spatial transcriptomics, Spatial genomics, Spatial proteomics.

By Product: Based on the Product, Global Spatial OMICS Market is segmented as; Instruments, Consumable, Software.

By Application: Based on the Application, Global Spatial OMICS Market is segmented as; Diagnostics, Translation research, Drug discovery and development, Single cell analysis, Cell biology, other application.

By Workflow: Based on the Workflow, Global Spatial OMICS Market is segmented as; Sample preparation, Instrumental analysis, Data analysis.

By End-User: Based on End-User, Global Spatial OMICS Market is segmented as; Academic & research institutes, Pharmaceutical and biotechnology companies, Contract research organizations, Other end-users.

By Region: This research also includes data for North America, Latin America, Asia-Pacific, Europe, Middle East & Africa.

Product Code: BIOT2507

1. Introduction

1.1. Scope of the report
1.2. Market segment analysis

2. Research Methodology

2.1. Research data source
- 2.1.1. Secondary Data
- 2.1.2. Primary Data
- 2.1.3. SPERs internal database
- 2.1.4. Premium insight from KOLs
2.2. Market size estimation
- 2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1. Drivers
- 4.1.2. Restraints
- 4.1.3. Opportunities
- 4.1.4. Challenges

5. Market variable and outlook

5.1. SWOT Analysis
- 5.1.1. Strengths
- 5.1.2. Weaknesses
- 5.1.3. Opportunities
- 5.1.4. Threats
5.2. PESTEL Analysis
- 5.2.1. Political Landscape
- 5.2.2. Economic Landscape
- 5.2.3. Social Landscape
- 5.2.4. Technological Landscape
- 5.2.5. Environmental Landscape
- 5.2.6. Legal Landscape
5.3. PORTERs Five Forces
- 5.3.1. Bargaining power of suppliers
- 5.3.2. Bargaining power of buyers
- 5.3.3. Threat of Substitute
- 5.3.4. Threat of new entrant
- 5.3.5. Competitive rivalry
5.4. Heat Map Analysis

6. Competitive Landscape

6.1. Global Spatial OMICS Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Spatial OMICS Market

7. Global Spatial OMICS Market, By Technology (USD Million) 2021-2034

7.1. Spatial transcriptomics
7.2. Spatial genomics
7.3. Spatial proteomics

8. Global Spatial OMICS Market, By Product (USD Million) 2021-2034

8.1. Instruments
- 8.1.1. Sequencing platforms
- 8.1.2. IHC
- 8.1.3. Microscopy
- 8.1.4. Flow cytometry
- 8.1.5. Mass spectrometry
- 8.1.6. Other types
8.2. Consumables
8.3. Software
- 8.3.1. Bioinformatics tools
- 8.3.2. Imaging tools
- 8.3.3. Storage & management databases

9. Global Spatial OMICS Market, By Application (USD Million) 2021-2034

9.1. Diagnostics
9.2. Translation research
9.3. Drug discovery and development
9.4. Single cell analysis
9.5. Cell biology
9.6. Other applications

10. Global Spatial OMICS Market, By Workflow (USD Million) 2021-2034

10.1. Sample preparation
10.2. Instrumental analysis
10.3. Data analysis

11. Global Spatial OMICS Market, By End-User (USD Million) 2021-2034

11.1. Academic & research institutes
11.2. Pharmaceutical and biotechnology companies
11.3. Contract research organizations
11.4. Other end-users

12. Global Spatial OMICS Market, (USD Million) 2021-2034

13.1. Global Spatial OMICS Market Size and Market Share

13. Global Spatial OMICS Market, By Region, (USD Million) 2021-2034

13.1. Asia-Pacific
- 13.1.1. Australia
- 13.1.2. China
- 13.1.3. India
- 13.1.4. Japan
- 13.1.5. South Korea
- 13.1.6. Rest of Asia-Pacific
13.2. Europe
- 13.2.1. France
- 13.2.2. Germany
- 13.2.3. Italy
- 13.2.4. Spain
- 13.2.5. United Kingdom
- 13.2.6. Rest of Europe
13.3. Middle East and Africa
- 13.3.1. Kingdom of Saudi Arabia
- 13.3.2. United Arab Emirates
- 13.3.3. Qatar
- 13.3.4. South Africa
- 13.3.5. Egypt
- 13.3.6. Morocco
- 13.3.7. Nigeria
- 13.3.8. Rest of Middle-East and Africa
13.4. North America
- 13.4.1. Canada
- 13.4.2. Mexico
- 13.4.3. United States
13.5. Latin America
- 13.5.1. Argentina
- 13.5.2. Brazil
- 13.5.3. Rest of Latin America

14. Company Profile

14.1. 10x Genomics
- 14.1.1. Company details
- 14.1.2. Financial outlook
- 14.1.3. Product summary
- 14.1.4. Recent developments
14.2. Akoya Biosciences, Inc
- 14.2.1. Company details
- 14.2.2. Financial outlook
- 14.2.3. Product summary
- 14.2.4. Recent developments
14.3. Bio-Techne Corporation
- 14.3.1. Company details
- 14.3.2. Financial outlook
- 14.3.3. Product summary
- 14.3.4. Recent developments
14.4. BioSpyder, Inc
- 14.4.1. Company details
- 14.4.2. Financial outlook
- 14.4.3. Product summary
- 14.4.4. Recent developments
14.5. Bruker Corporation
- 14.5.1. Company details
- 14.5.2. Financial outlook
- 14.5.3. Product summary
- 14.5.4. Recent developments
14.6. Danaher Corporation
- 14.6.1. Company details
- 14.6.2. Financial outlook
- 14.6.3. Product summary
- 14.6.4. Recent developments
14.7. Diagenode Diagnostics (Hologic, Inc)
- 14.7.1. Company details
- 14.7.2. Financial outlook
- 14.7.3. Product summary
- 14.7.4. Recent developments
14.8. Ionpath, Inc
- 14.8.1. Company details
- 14.8.2. Financial outlook
- 14.8.3. Product summary
- 14.8.4. Recent developments
14.9. Millennium Science Pty Ltd
- 14.9.1. Company details
- 14.9.2. Financial outlook
- 14.9.3. Product summary
- 14.9.4. Recent developments
14.10. NanoString Technologies, Inc
- 15.10.1. Company details
- 15.10.2. Financial outlook
- 15.10.3 Product summary
- 15.10.4. Recent developments
14.11. Others